Acceder Registro /

Natalia Cutillas Aulló

Buscador

Marco A, Ashoo P, Hernandez-Garcia S, Martinez-Rodriguez P, Cutillas N, Vollrath A, Jordan D, Janiak C, Gandia-Herrero F, Ruiz J. Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains. J Med Chem. 2024 Mar 7. doi: 10.1021/acs.jmedchem.3c01869. Online ahead of print. PubMed PMID: 38451016.
AÑO: 2024; IF: 7.3
Marco A, Vigueras G, Busto N, Cutillas N, Bautista D, Ruiz J. Novel valproate half-sandwich rhodium and iridium conjugates to fight against multidrug-resistant Gram-positive bacteria. Dalton Trans. 2023 Oct 3;52(38):13482-13486. doi: 10.1039/d3dt01678a. PubMed PMID: 37358044.
AÑO: 2023; IF: 4.0
Novohradsky V, Marco A, Markova L, Cutillas N, Ruiz J, Brabec V. Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells. J Med Chem. 2023 Jul 27;66(14):9766-9783. doi: 10.1021/acs.jmedchem.3c00586. Epub 2023 Jul 6. PubMed PMID: 37410386; PubMed Central PMCID: PMC10388354.
AÑO: 2023; IF: 7.3
Busto N, Vigueras G, Cutillas N, Garcia B, Ruiz J. Inert cationic iridium(III) complexes with phenanthroline-based ligands: application in antimicrobial inactivation of multidrug-resistant bacterial strains. Dalton Trans. 2022 Jun 27;51(25):9653-9663. doi: 10.1039/d2dt00752e. PubMed PMID: 35713595.
AÑO: 2022; IF: 4.0
Ortega-Forte E, Hernandez-Garcia S, Vigueras G, Henarejos-Escudero P, Cutillas N, Ruiz J, Gandia-Herrero F. Potent anticancer activity of a novel iridium metallodrug via oncosis. Cell Mol Life Sci. 2022 Sep 6;79(10):510. doi: 10.1007/s00018-022-04526-5. PubMed PMID: 36066676; PubMed Central PMCID: PMC9448686.
AÑO: 2022; IF: 8.0

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R